FDA approves Optune Pax, a wearable electric-field device, for locally advanced pancreatic cancer
Evidence stage: Later-Stage HumanRegulatory status: FDA Approved
In the randomized, phase 3 PANOVA-3 trial, adding Tumor Treating Fields (TTFields) -- a wearable device that emits alternating electric fields through skin-worn arrays -- to standard chemotherapy significantly extended…
Primary source cited
Last reviewed